Join us on Saturday, 14 December 2024, at 16:00 (GMT+8) for the webinar on An Update on Normal Pressure Glaucoma
This session, "An Update on Normal Pressure Glaucoma," will provide a comprehensive look at current diagnostic practices, innovative treatment options, and evolving research in managing this complex condition. Join us to gain valuable insights from experts dedicated to enhancing patient care and outcomes in glaucoma management.
All participants of the Webinar will receive a certificate of attendance.
Not sure when the webinar takes place in your location? Click here to convert the Webinar time to your local time.
This presentation will review the current recommendations for the treatment of normal tension glaucoma, starting with medical treatment, both in terms of hypotensive drugs and others whose effects are independent of intraocular pressure control, laser and possible surgical options for the control of these patients.
This talk would highlight the importance of Non IOP related factors related to glaucomatous damage and its progression. It would describe the multi-dimensional pathology of Normal tension glaucoma including vascular, neurodegenerative factors. It would also briefly cover the role of corneal biomechanics, IOP fluctuations, molecular factors and ischemia using different clinical examples. The audience would understand the application of these mechanisms in the clinics while managing patients that ...
This talk would highlight the importance of Non IOP related factors related to glaucomatous damage and its progression. It would describe the multi-dimensional pathology of Normal tension glaucoma including vascular, neurodegenerative factors. It would also briefly cover the role of corneal biomechanics, IOP fluctuations, molecular factors and ischemia using different clinical examples. The audience would understand the application of these mechanisms in the clinics while managing patients that progress despite of normal intra ocular pressure.
Trabeculectomy can effectively lower intraocular pressure (IOP) and slow visual field progression in NTG patients. Previous studies reported mean postoperative IOP below 10 mmHg can significantly improve the mean deviation (MD) slopes post-surgery. While trabeculectomy is generally safe, aiming for the very low IOP targets may complicate surgical outcomes. In our practice, NTG patients appear to have IOP fluctuates in the higher range. When the disease can’t be controlled with medications, ...
Trabeculectomy can effectively lower intraocular pressure (IOP) and slow visual field progression in NTG patients. Previous studies reported mean postoperative IOP below 10 mmHg can significantly improve the mean deviation (MD) slopes post-surgery. While trabeculectomy is generally safe, aiming for the very low IOP targets may complicate surgical outcomes. In our practice, NTG patients appear to have IOP fluctuates in the higher range. When the disease can’t be controlled with medications, trabeculectomy is generally the treatment of choice with the target pressure in the low teen range. 5-year post-operative outcomes and complications was reviewed.